Literature DB >> 21687940

Icariin induces apoptosis in mouse MLTC-10 Leydig tumor cells through activation of the mitochondrial pathway and down-regulation of the expression of piwil4.

Qi Wang1, Jie Hao, Jun Pu, Lina Zhao, Zhilan Lü, Jiangang Hu, Qiubo Yu, Yingxiong Wang, Yi Xie, Gang Li.   

Abstract

The Leydig cell tumor, derived from interstitial cells, is a rare neoplasm. In most cases, Leydig cell tumors are benign, however, if the tumor is malignant, no effective treatments are currently available. In this study, we aimed to evaluate the effects of icariin on the growth of the mouse Leydig tumor cell line MLTC-1 and to examine its underlying mechanism. Icariin caused a dose-dependent decrease in the viability of MLTC-1 cells, which coincided with an increase in cell apoptosis through regulation of the expression of Bcl-2/Bax and cytochrome c, activation of caspase-9 and -3. Moreover, the pro-apoptotic effect of icariin on MLTC-1 cells is related to piwil4, since icariin induced a decrease in piwil4 protein expression and piwil4 silencing significantly enhanced the cytotoxic effects of icariin in MLTC-1 cells. These findings suggest a novel anticancer effect of icariin in Leydig cell tumor through activation of the mitochondrial pathway and down-regulation of the expression of piwil4.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21687940     DOI: 10.3892/ijo.2011.1086

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  8 in total

1.  Icariin potentiates the antitumor activity of gemcitabine in gallbladder cancer by suppressing NF-κB.

Authors:  Dian-cai Zhang; Jin-long Liu; Yong-bin Ding; Jian-guo Xia; Guo-yu Chen
Journal:  Acta Pharmacol Sin       Date:  2012-12-31       Impact factor: 6.150

2.  Bioactive molecule Icariin inhibited proliferation while enhanced apoptosis and autophagy of rat airway smooth muscle cells in vitro.

Authors:  Lihong Yang; Bo Xiao; Lixia Hou; Guiming Zhou; Biwen Mo; Dong Yao
Journal:  Cytotechnology       Date:  2019-10-03       Impact factor: 2.058

3.  Icariin displays anticancer activity against human esophageal cancer cells via regulating endoplasmic reticulum stress-mediated apoptotic signaling.

Authors:  Chongxi Fan; Yang Yang; Yong Liu; Shuai Jiang; Shouyin Di; Wei Hu; Zhiqiang Ma; Tian Li; Yifang Zhu; Zhenlong Xin; Guiling Wu; Jing Han; Xiaofei Li; Xiaolong Yan
Journal:  Sci Rep       Date:  2016-02-19       Impact factor: 4.379

Review 4.  The Anticancer Properties of Herba Epimedii and Its Main Bioactive Componentsicariin and Icariside II.

Authors:  Meixia Chen; Jinfeng Wu; Qingli Luo; Shuming Mo; Yubao Lyu; Ying Wei; Jingcheng Dong
Journal:  Nutrients       Date:  2016-09-13       Impact factor: 5.717

5.  Icariin, a Novel Blocker of Sodium and Calcium Channels, Eliminates Early and Delayed Afterdepolarizations, As Well As Triggered Activity, in Rabbit Cardiomyocytes.

Authors:  Wanzhen Jiang; Mengliu Zeng; Zhenzhen Cao; Zhipei Liu; Jie Hao; Peipei Zhang; Youjia Tian; Peihua Zhang; Jihua Ma
Journal:  Front Physiol       Date:  2017-05-29       Impact factor: 4.566

6.  The Clinical Significance of PIWIL3 and PIWIL4 Expression in Pancreatic Cancer.

Authors:  Weiyao Li; Javier Martinez-Useros; Nuria Garcia-Carbonero; Maria J Fernandez-Aceñero; Alberto Orta; Luis Ortega-Medina; Sandra Garcia-Botella; Elia Perez-Aguirre; Luis Diez-Valladares; Angel Celdran; Jesús García-Foncillas
Journal:  J Clin Med       Date:  2020-04-26       Impact factor: 4.241

Review 7.  Anti-Cancer Properties of the Naturally Occurring Aphrodisiacs: Icariin and Its Derivatives.

Authors:  Hui-Li Tan; Kok-Gan Chan; Priyia Pusparajah; Surasak Saokaew; Acharaporn Duangjai; Learn-Han Lee; Bey-Hing Goh
Journal:  Front Pharmacol       Date:  2016-06-29       Impact factor: 5.810

Review 8.  Improvement of Testicular Steroidogenesis Using Flavonoids and Isoflavonoids for Prevention of Late-Onset Male Hypogonadism.

Authors:  Luc J Martin; Mohamed Touaibia
Journal:  Antioxidants (Basel)       Date:  2020-03-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.